The world of oncology is shifting its focus from the cancer cells themselves to the complex environment that sustains them. Ivan Kairatov, a biopharma expert with extensive experience in research and development, joins us to discuss a groundbreaking discovery from the University of Oklahoma. For
The global healthcare infrastructure currently operates under a massive weight of digital information that often proves to be more of a burden than a benefit to the medical professionals who need it most. While the industry has spent the last several years digitizing every patient interaction and
The profound disconnect between the high percentage of cancer patients willing to participate in clinical research and the small fraction who actually enroll has long been an industry bottleneck. While data consistently shows that more than seventy percent of individuals battling cancer express a
Operating a modern biopharmaceutical facility in the Asia-Pacific region feels less like solving a static puzzle and more like managing a pressurized hydraulic system where fixing a leak in one valve inevitably increases the strain on the next. Engineers and plant managers across the region are
The realization that trillions of microorganisms residing within the human digestive tract exert a profound influence on the systemic distribution of synthetic nanocarriers has completely revolutionized modern oncological strategies. Researchers have shifted their focus from merely optimizing the
The pharmaceutical industry is entering a period of radical restructuring as the wall between computational design and physical manufacturing finally begins to crumble under the weight of a multi-billion dollar strategic alliance. This partnership between Insilico Medicine and Bora Pharmaceuticals,
